Inhibitory effect of povidone-iodine for the antigen expression of human cytomegalovirus

In Vivo

Volumn 13, Issue 3, 1999, Pages 239-241

  Numazaki, Kei ^a   Asanuma, Hideomi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antiviral desinfection; Human cytomegalovirus (CMV); Povidone iodine (PVP I)

Indexed keywords

DISINFECTANT AGENT; IMMEDIATE EARLY PROTEIN; POVIDONE IODINE; VIRUS ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; NONHUMAN; VIRUS TRANSMISSION;

EID: 0032803447     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Numazaki K and Chiba S: Current aspects of diagnosis and treatment of cytomegalovirus infections in infants. Clin Diagn Virol 8: 169-181, 1997.
2. Rackur H: New aspects of mechanism of action of povidone-iodine. J Hosp Infect 6 (supplement): 13-23, 1985.
3. Numazaki K, Nagata N and Chiha S: Evaluation of the shell vial pre-CPE method using monoclonal antibodies of human cytomegalovirus infection in the field of pediatrics. In Vivo 6: 513-516, 1992.
4. Numazaki K, Nagata N, Sato T and Chiba, S: Effect of glycyrrhizin, cyclosporin A, and tumor necrosis factor a on infection of U-937 and MRC-5 cells by human cytomegalovirus. J Leukoc Biol 55: 24-28, 1994.
5. Stagno S and Cloud GA: Working parents: the impact of day care and breast-feeding on cytomegalovirus infections in offspring. Proc Natl Acad Sci USA 97; 2384-2389, 1994.
6. Whitley RJ, Cloud G, Gruber W, et al: Ganciclovir treatment of symptomatic congenital cytomegalovirus infection; results of phase II study. J Infect Dis 175: 1080-1086, 1997.
7. Harmsen MC, Swart PJ, de Béthune M-P, et al: Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J Infect Dis 172; 380-388, 1995.
8. Numazaki K and Chiba S: Natural course and trial of treatment for infantile liver dysfunction associated with cytomegalovirus infections. In Vivo 7: 477-480, 1993.
9. Numazaki K, Umetsu M and Chiha S: Effect of glycyrrhizin in children with liver dysfunction associated with cytomegalovirus infection. Tohoku J Exp Med 172; 147-153, 1994.
10. Asanaka M, Itagaki A and Kurimura T: In vitro study on inactivation of various viruses including human immunodeficiency virus (HIV) by PVP-I. In: Selwyn S. eds. Procccdlpg of the First Asian/Pacific Congress on Antisepsis, International Congress and Symposium Scries. London, New York; Royal Society of Medicine Services Limited, pp. 21-26. 1988.